TY - JOUR AU - Soriano, V. AU - Barreiro, P. PY - 2020 DA - 2020// TI - Impact of new coronavirus epidemics on HIV-infected patients JO - AIDS Rev VL - 22 UR - https://doi.org/10.24875/AIDSRev.M20000031 DO - 10.24875/AIDSRev.M20000031 ID - Soriano2020 ER - TY - JOUR AU - Li, G. AU - Fan, Y. AU - Lai, Y. AU - Han, T. AU - Li, Z. AU - Zhou, P. PY - 2020 DA - 2020// TI - Coronavirus infections and immune responses JO - J Med Virol VL - 92 UR - https://doi.org/10.1002/jmv.25685 DO - 10.1002/jmv.25685 ID - Li2020 ER - TY - JOUR AU - Cui, J. AU - Li, F. AU - Shi, Z. L. PY - 2019 DA - 2019// TI - Origin and evolution of pathogenic coronaviruses JO - Nat Rev Microbiol VL - 17 UR - https://doi.org/10.1038/s41579-018-0118-9 DO - 10.1038/s41579-018-0118-9 ID - Cui2019 ER - TY - JOUR AU - Lipsitch, M. AU - Cohen, T. AU - Cooper, B. AU - Robins, J. M. AU - Ma, S. AU - James, L. PY - 2003 DA - 2003// TI - Transmission dynamics and control of severe acute respiratory syndrome JO - Science (New York, NY) VL - 300 UR - https://doi.org/10.1126/science.1086616 DO - 10.1126/science.1086616 ID - Lipsitch2003 ER - TY - JOUR AU - Wallinga, J. AU - Teunis, P. PY - 2004 DA - 2004// TI - Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures JO - Am J Epidemiol VL - 160 UR - https://doi.org/10.1093/aje/kwh255 DO - 10.1093/aje/kwh255 ID - Wallinga2004 ER - TY - JOUR AU - Lin, Q. AU - Chiu, A. P. AU - Zhao, S. AU - He, D. PY - 2018 DA - 2018// TI - Modeling the spread of Middle East respiratory syndrome coronavirus in Saudi Arabia JO - Stat Methods Med Res VL - 27 UR - https://doi.org/10.1177/0962280217746442 DO - 10.1177/0962280217746442 ID - Lin2018 ER - TY - BOOK PY - 2020 DA - 2020// TI - Coronavirus disease 2019 (COVID-19) Situation Report – 197 ID - ref7 ER - TY - JOUR AU - Swaminathan, S. AU - Nagendran, G. PY - 2008 DA - 2008// TI - HIV and tuberculosis in India JO - J Biosci VL - 33 UR - https://doi.org/10.1007/s12038-008-0071-2 DO - 10.1007/s12038-008-0071-2 ID - Swaminathan2008 ER - TY - BOOK PY - 2019 DA - 2019// TI - Global HIV & AIDS statistics — 2019 fact sheet ID - ref9 ER - TY - BOOK PY - 2009 DA - 2009// TI - TB/HIV FACTS 2009 ID - ref10 ER - TY - JOUR AU - Dirlikov, E. AU - Raviglione, M. AU - Scano, F. PY - 2015 DA - 2015// TI - Global tuberculosis control: toward the 2015 targets and beyond JO - Ann Intern Med VL - 163 UR - https://doi.org/10.7326/M14-2210 DO - 10.7326/M14-2210 ID - Dirlikov2015 ER - TY - BOOK PY - 2014 DA - 2014// TI - USAID Report on the twin epidemics: HIV AND TB Co-infection ID - ref12 ER - TY - JOUR AU - Gupta, R. K. AU - Lucas, S. B. AU - Fielding, K. L. AU - Lawn, S. D. PY - 2015 DA - 2015// TI - Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis JO - AIDS (London, England) VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000802 DO - 10.1097/QAD.0000000000000802 ID - Gupta2015 ER - TY - STD TI - Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Thelacent. 2020; doi: https://doi.org/https://doi.org/10.1016/S2352-3018(20)30105-3. ID - ref14 ER - TY - JOUR AU - Gralinski, L. E. AU - Baric, R. S. PY - 2015 DA - 2015// TI - Molecular pathology of emerging coronavirus infections JO - J Pathol VL - 235 UR - https://doi.org/10.1002/path.4454 DO - 10.1002/path.4454 ID - Gralinski2015 ER - TY - JOUR AU - Ogimi, C. AU - Waghmare, A. A. AU - Kuypers, J. M. AU - Xie, H. AU - Yeung, C. C. AU - Leisenring, W. M. PY - 2017 DA - 2017// TI - Clinical significance of human coronavirus in Bronchoalveolar lavage samples from hematopoietic cell transplant recipients and patients with hematologic malignancies JO - Clin Infect Dis VL - 64 UR - https://doi.org/10.1093/cid/cix160 DO - 10.1093/cid/cix160 ID - Ogimi2017 ER - TY - JOUR AU - Ogimi, C. AU - Englund, J. A. AU - Bradford, M. C. AU - Qin, X. AU - Boeckh, M. AU - Waghmare, A. PY - 2019 DA - 2019// TI - Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an Immunocompromised state JO - J Pediatric Infect Dis Soc VL - 8 UR - https://doi.org/10.1093/jpids/pix093 DO - 10.1093/jpids/pix093 ID - Ogimi2019 ER - TY - JOUR AU - Diedrich, C. R. AU - Flynn, J. L. PY - 2011 DA - 2011// TI - HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? JO - Infect Immun VL - 79 UR - https://doi.org/10.1128/IAI.01126-10 DO - 10.1128/IAI.01126-10 ID - Diedrich2011 ER - TY - JOUR AU - Geldmacher, C. AU - Zumla, A. AU - Hoelscher, M. PY - 2012 DA - 2012// TI - Interaction between HIV and mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis JO - Curr Opin HIV AIDS VL - 7 ID - Geldmacher2012 ER - TY - JOUR AU - Ahmed, A. AU - Rakshit, S. AU - Vyakarnam, A. PY - 2016 DA - 2016// TI - HIV-TB co-infection: mechanisms that drive reactivation of mycobacterium tuberculosis in HIV infection JO - Oral Dis VL - 22 UR - https://doi.org/10.1111/odi.12390 DO - 10.1111/odi.12390 ID - Ahmed2016 ER - TY - JOUR AU - Esmail, H. AU - Riou, C. AU - Bruyn, E. D. AU - Lai, R. P. AU - Harley, Y. X. R. AU - Meintjes, G. PY - 2018 DA - 2018// TI - The immune response to mycobacterium tuberculosis in HIV-1-Coinfected persons JO - Annu Rev Immunol VL - 36 UR - https://doi.org/10.1146/annurev-immunol-042617-053420 DO - 10.1146/annurev-immunol-042617-053420 ID - Esmail2018 ER - TY - BOOK PY - 2020 DA - 2020// TI - Global research on coronavirus disease (COVID-19) ID - ref22 ER - TY - STD TI - Nordic Cochrane Centre The Cochrane Collaboration. Review Manager (RevMan) [Computer program] Version Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014. ID - ref23 ER - TY - STD TI - Suurmond R, van Rhee, H, Hak T introduction, comparison and validation of meta-essentials: A free and simple tool for meta-analysis [computer program]. Research synthesis methods. Vol. 8, Iss 4, 537–553, 2017. https://doi.org/https://doi.org/10.1002/jrsm.1260. ID - ref24 ER - TY - STD TI - Wells GA, B Shea, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 29 July 2020. UR - http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ID - ref25 ER - TY - JOUR AU - Wang, M. AU - Cao, R. AU - Zhang, L. AU - Yang, X. AU - Liu, J. AU - Xu, M. PY - 2020 DA - 2020// TI - Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro JO - Cell Res VL - 30 UR - https://doi.org/10.1038/s41422-020-0282-0 DO - 10.1038/s41422-020-0282-0 ID - Wang2020 ER - TY - STD TI - Del AJ, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, et al. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann Intern Med 2020; https://doi.org/https://doi.org/10.7326/M20-3689. ID - ref27 ER - TY - JOUR AU - Chen, T. L. AU - Dai, Z. AU - Mo, P. AU - Li, X. AU - Ma, Z. AU - Song, S. PY - 2020 DA - 2020// TI - Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study JO - J Gerontol A Biol Sci Med Sci VL - 20 ID - Chen2020 ER - TY - JOUR AU - Liu, W. AU - Fontanet, A. AU - Zhang, P. H. AU - Zhan, L. AU - Xin, Z. T. AU - Tang, F. PY - 2006 DA - 2006// TI - Pulmonary tuberculosis and SARS, China JO - Emerg Infect Dis VL - 12 UR - https://doi.org/10.3201/eid1204.050264 DO - 10.3201/eid1204.050264 ID - Liu2006 ER - TY - JOUR AU - Low, J. G. AU - Lee, C. C. AU - Leo, Y. S. PY - 2004 DA - 2004// TI - Severe acute respiratory syndrome and pulmonary tuberculosis JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/421396 DO - 10.1086/421396 ID - Low2004 ER - TY - JOUR AU - Wong, A. T. Y. AU - Tsang, O. T. Y. AU - Wong, K. H. AU - Wong, M. Y. F. AU - Lim, W. L. AU - Zheng, B. J. PY - 2004 DA - 2004// TI - Coronavirus infection in an AIDS patient JO - AIDS VL - 18 UR - https://doi.org/10.1097/00002030-200403260-00021 DO - 10.1097/00002030-200403260-00021 ID - Wong2004 ER - TY - JOUR AU - Alfaraj, S. H. AU - Al-Tawfiq, J. A. AU - Altuwaijri, T. A. AU - Memish, Z. A. PY - 2017 DA - 2017// TI - Middle East respiratory syndrome coronavirus and pulmonary tuberculosis coinfection: implications for infection control JO - Intervirology VL - 60 UR - https://doi.org/10.1159/000477908 DO - 10.1159/000477908 ID - Alfaraj2017 ER - TY - STD TI - Singh A, Gupta A, Das K. Severe Acute Respiratory Syndrome Coronavirus-2 and Pulmonary Tuberculosis Coinfection: Double Trouble. Res Square. 2020. https://doi.org/10.21203/rs.3.rs-22464/v1. ID - ref33 ER - TY - STD TI - He G, Wu J, Shi J, Dai J, Gamber M, Jiang X, et al. COVID-19 in tuberculosis patients: a report of three cases. J Med Virol. 2020. https://doi.org/10.1002/jmv.25943. ID - ref34 ER - TY - STD TI - Cutler T, Scales D, Levine W, Schluger N, O'Donnell M. A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis. Am J Respir Crit Care Med 2020; https://www.atsjournals.org/doi/pdf/https://doi.org/10.1164/rccm.202003-0828IM. ID - ref35 ER - TY - STD TI - Çınar OE, Sayınalp B, Karakulak EA, Karataş AA, Velet M, İnkaya AÇ, et al. Convalescent (immune) plasma treatment in a myelodysplastic covid-19 patient with disseminated tuberculosis. Transfus Apher Sci 2020; https://doi.org/https://doi.org/10.1016/j.transci.2020.102821:102821. ID - ref36 ER - TY - JOUR AU - Faqihi, F. AU - Alharthy, A. AU - Noor AlFateh, B. A. AU - Balahmar, A. AU - Karakitsos, D. PY - 2020 DA - 2020// TI - COVID-19 in a patient with active tuberculosis: A rare case-report JO - Respir Med Case Rep VL - 31 ID - Faqihi2020 ER - TY - STD TI - Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv BioRxiv 2020; doi: https://doi.org/https://doi.org/10.1101/2020.03.10.20033795. ID - ref38 ER - TY - STD TI - Tham SM, Lim WY, Lee CK, Loh J, Premkumar A, Yan B, et al. Four patients with COVID-19 and tuberculosis, Singapore, April–may 2020. Emerg Infect Dis. 2020. https://doi.org/10.3201/eid2611.202752. ID - ref39 ER - TY - STD TI - Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020. https://doi.org/10.1183/13993003.01708-2020. ID - ref40 ER - TY - JOUR AU - Du, R. H. AU - Liang, L. R. AU - Yang, C. Q. AU - Wang, W. AU - Cao, T. Z. AU - Li, M. PY - 2020 DA - 2020// TI - Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study JO - Eur Respir J VL - 55 UR - https://doi.org/10.1183/13993003.00524-2020 DO - 10.1183/13993003.00524-2020 ID - Du2020 ER - TY - BOOK AU - Davies, M. PY - 2020 DA - 2020// TI - HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa ID - Davies2020 ER - TY - BOOK AU - Karla, S. L. AU - Haw, N. J. L. AU - Uy, J. PY - 2020 DA - 2020// TI - Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19 ID - Karla2020 ER - TY - STD TI - Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Eur Acad Allergy Clin Immunol 2020; https://doi.org/https://doi.org/10.1111/all.14238. ID - ref44 ER - TY - JOUR AU - Zhang, Y. AU - Deng, A. AU - Hu, T. AU - Chen, X. AU - Zhuang, Y. AU - Tan, X. AU - Zheng, H. AU - Sun, L. AU - Li, Y. AU - Zhong, H. AU - He, J. AU - Song, T. AU - Kang, M. PY - 2020 DA - 2020// TI - Clinical outcome and influencing factors of new cases of coronavirus pneumonia in Guangdong province JO - Chin J Epidemiol VL - 41 ID - Zhang2020 ER - TY - STD TI - Zhang H, Yuan Y. Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients with Moderate to Severe COVID −19. https://clinicaltrials.gov/ct2/show/NCT04338802. Accessed 15 May 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04338802 ID - ref46 ER - TY - STD TI - Motta I, Centis R, D’Ambrosio L, García-García J, Goletti D, Gualano G, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; https://doi.org/https://doi.org/10.1016/j.pulmoe.2020.05.002. ID - ref47 ER - TY - JOUR AU - Li, X. AU - Xu, S. AU - Yu, M. AU - Wang, K. AU - Tao, Y. AU - Zhou, Y. PY - 2020 DA - 2020// TI - Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan JO - J Allergy Clin Immunol VL - 146 UR - https://doi.org/10.1016/j.jaci.2020.04.006 DO - 10.1016/j.jaci.2020.04.006 ID - Li2020 ER - TY - STD TI - Liu C, Yu Y, Fleming J, Wang T, Shen S, Wang Y, et al. Severe COVID-19 cases with a history of active or latent tuberculosis. Int J Tuberc Lung Dis 2020;http://dx.doi.org/https://doi.org/10.5588/ijld.20.0163. ID - ref49 ER - TY - JOUR PY - 2020 DA - 2020// TI - Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-march 16, 2020 JO - MMWR Morb Mortal Wkly Rep VL - 69 UR - https://doi.org/10.15585/mmwr.mm6912e2 DO - 10.15585/mmwr.mm6912e2 ID - ref50 ER - TY - JOUR AU - Shiau, S. AU - Krause, K. D. AU - Valera, P. AU - Swaminathan, S. AU - Halkitis, P. N. PY - 2020 DA - 2020// TI - The burden of COVID-19 in people living with HIV: a syndemic perspective JO - AIDS Behav VL - 24 UR - https://doi.org/10.1007/s10461-020-02871-9 DO - 10.1007/s10461-020-02871-9 ID - Shiau2020 ER - TY - BOOK PY - 2017 DA - 2017// TI - HIV Continuum of Care, U.S., 2014, Overall and by Age, Race/Ethnicity, Transmission Route and Sex ID - ref52 ER - TY - JOUR AU - Hong, K. H. AU - Lee, S. W. AU - Kim, T. S. AU - Huh, H. J. AU - Lee, J. AU - Kim, S. Y. PY - 2020 DA - 2020// TI - Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea JO - Ann Lab Med VL - 40 UR - https://doi.org/10.3343/alm.2020.40.5.351 DO - 10.3343/alm.2020.40.5.351 ID - Hong2020 ER - TY - JOUR AU - Piatek, A. S. AU - Van, C. M. AU - Alexander, H. AU - Coggin, W. L. AU - Rehr, M. AU - Van, K. S. PY - 2013 DA - 2013// TI - GeneXpert for TB diagnosis: planned and purposeful implementation JO - Glob Health Sci Pract VL - 1 UR - https://doi.org/10.9745/GHSP-D-12-00004 DO - 10.9745/GHSP-D-12-00004 ID - Piatek2013 ER - TY - BOOK PY - 2016 DA - 2016// TI - Automated real-time DNA amplification test for rapid and simultaneous detection of TB and rifampicin resistance ID - ref55 ER - TY - STD TI - Cattamanchi A, Ssewenyana I, Nabatanzi R, Miller CR, Den BS, Davis JL, et al. Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients. PLoS One. 2012;7(6). ID - ref56 ER - TY - BOOK PY - 2018 DA - 2018// TI - Latent tuberculosis infection Updated and consolidated guidelines for programmatic management ID - ref57 ER - TY - JOUR AU - Savarino, A. PY - 2005 DA - 2005// TI - Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza JO - J Clin Virol VL - 34 UR - https://doi.org/10.1016/j.jcv.2005.03.005 DO - 10.1016/j.jcv.2005.03.005 ID - Savarino2005 ER - TY - JOUR AU - Baden, L. R. AU - Rubin, E. J. PY - 2020 DA - 2020// TI - Covid-19 - the search for effective therapy JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMe2005477 DO - 10.1056/NEJMe2005477 ID - Baden2020 ER - TY - JOUR AU - Sheahan, T. P. AU - Sims, A. C. AU - Leist, S. R. AU - Schafer, A. AU - Won, J. AU - Brown, A. J. PY - 2020 DA - 2020// TI - Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV JO - Nat Commun VL - 11 UR - https://doi.org/10.1038/s41467-019-13940-6 DO - 10.1038/s41467-019-13940-6 ID - Sheahan2020 ER - TY - STD TI - Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A, Doherty M. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID-19: initial assessment. J Int AIDS Soc. 2020. https://doi.org/10.1002/:jia2.25489. ID - ref61 ER - TY - JOUR AU - Acosta, E. P. AU - Kendall, M. A. AU - Gerber, J. G. AU - Alston-Smith, B. AU - Koletar, S. L. AU - Zolopa, A. R. PY - 2007 DA - 2007// TI - Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.00341-07 DO - 10.1128/AAC.00341-07 ID - Acosta2007 ER - TY - JOUR AU - Karanja, J. K. AU - Kiboi, N. G. AU - Nebere, S. N. AU - HO A. PY - 2016 DA - 2016// TI - Highly active antiretroviral therapy and anti-tuberculosis drug interactions with associated clinical implications: A review JO - J Drug Metab Toxicol VL - 7 ID - Karanja2016 ER - TY - BOOK PY - 2020 DA - 2020// TI - Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. From NIH website ID - ref64 ER - TY - JOUR AU - Vincent, M. J. AU - Bergeron, E. AU - Benjannet, S. AU - Erickson, B. R. AU - Rollin, P. E. AU - Ksiazek, T. G. PY - 2005 DA - 2005// TI - Chloroquine is a potent inhibitor of SARS coronavirus infection and spread JO - Virol J VL - 2 UR - https://doi.org/10.1186/1743-422X-2-69 DO - 10.1186/1743-422X-2-69 ID - Vincent2005 ER - TY - JOUR AU - Colson, P. AU - Rolain, J. M. AU - Raoult, D. PY - 2020 DA - 2020// TI - Chloroquine for the 2019 novel coronavirus JO - Int J Antimicrob Agents VL - 55 UR - https://doi.org/10.1016/j.ijantimicag.2020.105923 DO - 10.1016/j.ijantimicag.2020.105923 ID - Colson2020 ER - TY - STD TI - Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; https://doi.org/https://doi.org/10.1093/cid/ciaa237. ID - ref67 ER - TY - STD TI - Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic management of COVID-19 patients: A systematic review. Inf Prev Pract 2020; https://doi.org/https://doi.org/10.1016/j.infpip.2020.100061. ID - ref68 ER - TY - JOUR AU - Juurlink, D. N. PY - 2020 DA - 2020// TI - Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection JO - Can Med Assoc J VL - 192 UR - https://doi.org/10.1503/cmaj.200528 DO - 10.1503/cmaj.200528 ID - Juurlink2020 ER - TY - JOUR AU - Sousa, M. AU - Pozniak, A. AU - Boffito, M. PY - 2008 DA - 2008// TI - Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs JO - J Antimicrob Chemother VL - 62 UR - https://doi.org/10.1093/jac/dkn330 DO - 10.1093/jac/dkn330 ID - Sousa2008 ER - TY - JOUR AU - Marquez, B. AU - Bambeke, F. PY - 2011 DA - 2011// TI - ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions JO - Curr Drug Targets VL - 12 UR - https://doi.org/10.2174/138945011795378504 DO - 10.2174/138945011795378504 ID - Marquez2011 ER - TY - JOUR AU - Strydom, N. AU - Gupta, S. V. AU - Fox, W. S. AU - Via, L. E. AU - Bang, H. AU - Lee, M. PY - 2019 DA - 2019// TI - Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization JO - PLoS Med VL - 16 UR - https://doi.org/10.1371/journal.pmed.1002773 DO - 10.1371/journal.pmed.1002773 ID - Strydom2019 ER - TY - STD TI - Kalyesubula R, Perazella MA. Nephrotoxicity of HAART. AIDS Res Treat 2011 2011; https://doi.org/https://doi.org/10.1155/2011/562790. ID - ref73 ER - TY - JOUR AU - Tang, N. AU - Bai, H. AU - Chen, X. AU - Gong, J. AU - Li, D. AU - Sun, Z. PY - 2020 DA - 2020// TI - Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy JO - J Thromb Haemost VL - 18 UR - https://doi.org/10.1111/jth.14817 DO - 10.1111/jth.14817 ID - Tang2020 ER - TY - JOUR AU - Alhazzani, W. AU - Møller Morten, H. AU - Arabi, Y. M. AU - Loeb, M. AU - Gong, M. N. AU - Fan, E. PY - 2020 DA - 2020// TI - Surviving Sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) JO - Intensive Care Med VL - 48 UR - https://doi.org/10.1007/s00134-020-06022-5 DO - 10.1007/s00134-020-06022-5 ID - Alhazzani2020 ER -